Identification of thrombin activatable fibrinolysis inhibitor (TAFI) in human platelets
- 15 June 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (12) , 4844-4846
- https://doi.org/10.1182/blood-2002-09-2944
Abstract
Thrombin activatable fibrinolysis inhibitor (TAFI) is a carboxypeptidase B-like proenzyme that after activation down-regulates fibrinolysis. Platelets are known to contain antifibrinolytic factors that are secreted during platelet activation. Therefore, the presence of TAFI in platelets was analyzed. TAFI was identified in platelets in a concentration of about 50 ng/1 × 109 platelets and was secreted on platelet activation. Thrombin-mediated activation of platelet-derived TAFI resembled that of plasma-derived TAFI with respect to stimulation by thrombomodulin and spontaneous loss of activity at 37°C. The different glycosylation of platelet-derived TAFI compared with plasma-derived TAFI suggests that platelet-derived TAFI is synthesized in the megakaryocyte. This suggestion was substantiated by the detection of mRNA in the megakaryocytic cell lines DAMI and CHRF, representing the intermediate and late stages of megakaryocyte development. These results establish the presence of TAFI in platelets and suggest a role for platelet-derived TAFI in the protection of the clot against fibrinolysis.Keywords
This publication has 22 references indexed in Scilit:
- Insulin Resistance Is Associated with Increased Circulating Level of Thrombin-Activatable Fibrinolysis Inhibitor in Type 2 Diabetic PatientsJournal of Clinical Endocrinology & Metabolism, 2002
- Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphismsHuman Genetics, 2001
- Identification of polymorphisms in the promoter and the 3′ region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlledBlood, 2001
- Thrombin-Activatable Fibrinolysis Inhibitor (TAFI, Plasma Procarboxypeptidase B, Procarboxypeptidase R, Procarboxypeptidase U)Thrombosis Research, 2001
- Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosisBlood, 2000
- Inactivation of Active Thrombin-activable Fibrinolysis Inhibitor Takes Place by a Process That Involves Conformational Instability Rather Than Proteolytic CleavageJournal of Biological Chemistry, 2000
- Protein C Inhibitor Secreted from Activated Platelets Efficiently Inhibits Activated Protein C on Phosphatidylethanolamine of Platelet Membrane and MicrovesiclesPublished by Elsevier ,1998
- Identification and Characterization of Two Thrombin-activatable Fibrinolysis Inhibitor IsoformsThrombosis and Haemostasis, 1998
- Exposure of ligand-binding sites on platelet integrin αIIB/β3 by phosphorylation of the β3 subunitBiochemical Journal, 1996
- Platelet and Plasma Fibrinogens Are Identical Gene ProductsScience, 1974